Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAGMAT Trial
NCT05776914Phase 2Recruiting
- Start
- Apr 2024
- Primary completion
- Jun 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in irritable bowel syndrome (IBS). Started Apr 2024; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05776914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05776914.